跳至主要内容
临床试验/NCT06053827
NCT06053827已完成不适用

Embryo Transfer in Natural vs Substituted Cycle and the Scheduling Pattern of IVF

Clinique Ovo1 个研究点 分布在 1 个国家目标入组 1,207 人开始时间: 2023年9月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,207
试验地点
1
主要终点
Evaluate the clinical pregnancy rate of embryo transfer in natural vs substituted cycles

研究概览

简要总结

In frozen embryo transfer substituted cycles, patients are treated with progesterone and estrogen in an attempt to mimic the natural cycle and a transfer is planned whenever the endometrium is ready. In contrast, in frozen embryo transfer natural cycle patients are not taking any hormones, only triggered with hCG (human chorionic gonadotropin) when a dominant follicle is ready or they wait for the disappearance of the dominant follicle to plan the transfer date. Some doctors and centres shift towards using the substituted protocol in an attempt to make scheduling easier with less frequent ultrasounds.

This study will aim to compare clinical and biochemical pregnancy rates in patients who underwent frozen embryo transfers in natural cycles vs substituted cycles at the centre.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
— 至 40 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Age < 40 years old
  • Women having undergone either a frozen embryo transfer in natural cycle or substituted cycle
  • IVF and FET cycles done at Clinique OVO

排除标准

  • egg or embryo recipient
  • History of recurrent miscarriages, defined as ≥ 3 consecutive losses
  • Patients that needed Viagra, Plasma-Rich Platelet (PRP) or other modalities to improve their endometrial thickness
  • Uterine abnormalities
  • Abnormal hormonal profiles
  • FET Stimulated cycles
  • History of recurrent implantation failure defined as failed ≥ 2 euploid embryos transfer or ≥ 3 blastocysts

结局指标

主要结局

Evaluate the clinical pregnancy rate of embryo transfer in natural vs substituted cycles

时间窗: 6 to 8 weeks after Frozen Embryo Transfer

clinical pregnancy is the presence of fetal heartbeat at the viability ultrasound

次要结局

未报告次要终点

研究者

发起方
Clinique Ovo
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验